pubmed-article:7691301 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C0019764 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C0043092 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C0079720 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
pubmed-article:7691301 | lifeskim:mentions | umls-concept:C1304884 | lld:lifeskim |
pubmed-article:7691301 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:7691301 | pubmed:dateCreated | 1993-11-4 | lld:pubmed |
pubmed-article:7691301 | pubmed:abstractText | Lymphocyte subset abnormalities have been observed in a series of patients diagnosed with Wegener's granulomatosis (WG). Fifteen patients with WG were evaluated for lymphocyte subset abnormalities by two-color immunofluorescence flow cytometry. The WG group showed a decrease in CD4+ cells and an extraordinary increase in HLA-DR+ cells. The average percentages of HLA-DR+ cells of the normal group and WG group were 11.0 +/- 4.0 and 40.5 +/- 13.9% (CD3+HLA-DR+ = 20.3 + 9.4%). Within the CD8 family, CD8+57+, CD8+38+ and CD8+HLA-DR+ cells were markedly elevated. Our findings differ from other series which reported that the lymphocyte subsets in the peripheral blood of patients with WG were normal. | lld:pubmed |
pubmed-article:7691301 | pubmed:language | eng | lld:pubmed |
pubmed-article:7691301 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691301 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7691301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691301 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7691301 | pubmed:issn | 1018-2438 | lld:pubmed |
pubmed-article:7691301 | pubmed:author | pubmed-author:WatanabeYY | lld:pubmed |
pubmed-article:7691301 | pubmed:author | pubmed-author:IkedaMM | lld:pubmed |
pubmed-article:7691301 | pubmed:author | pubmed-author:InouyeTT | lld:pubmed |
pubmed-article:7691301 | pubmed:author | pubmed-author:KitaharaSS | lld:pubmed |
pubmed-article:7691301 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7691301 | pubmed:volume | 102 | lld:pubmed |
pubmed-article:7691301 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7691301 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7691301 | pubmed:pagination | 205-8 | lld:pubmed |
pubmed-article:7691301 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:meshHeading | pubmed-meshheading:7691301-... | lld:pubmed |
pubmed-article:7691301 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:7691301 | pubmed:articleTitle | Distinctive increases in HLA-DR+ and CD8+57+ lymphocyte subsets in Wegener's granulomatosis. | lld:pubmed |
pubmed-article:7691301 | pubmed:affiliation | Department of Otolaryngology, National Defense Medical College, Saitama, Japan. | lld:pubmed |
pubmed-article:7691301 | pubmed:publicationType | Journal Article | lld:pubmed |